Neonatal PFAS Exposure: Timing and Vulnerability
Neonates are uniquely vulnerable to PFAS toxicity due to immature detoxification systems, rapidly developing organ systems, and ongoing PFAS exposure through breast milk. PFAS accumulated during fetal life continue to affect newborn physiology.
Neonatal Immune and Inflammatory Effects
Newborns with higher cord blood PFAS levels show altered immune cell populations and cytokine profiles at birth. These immune programming effects may increase susceptibility to neonatal infections and affect long-term immune development through childhood.
Birth Weight and Growth Parameters
Large cohort studies consistently show inverse associations between maternal PFAS levels and birth weight. Low birth weight associated with PFAS exposure programs metabolic disease risk in adulthood through developmental origins of health and disease mechanisms.
NICU and Pediatric Follow-Up
Neonatal intensive care units serving PFAS-contaminated communities should incorporate PFAS exposure documentation into neonatal records. Long-term neurodevelopmental follow-up for PFAS-exposed neonates guides early intervention planning.